Fig. 1From: Development and validation of postoperative circulating tumor DNA combined with clinicopathological risk factors for recurrence prediction in patients with stage I-III colorectal cancerFlowchart depicting the patient selection, sample collection, and study overview. CRC colorectal cancer, NGS next-generation sequencing, RFS recurrence-free survival, ctDNA circulating tumor DNABack to article page